Scientists are no longer just cataloging the damage that comes with age, they are starting to rewire the machinery inside ...
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
Abstract: A concept for the fault-tolerant control of a primary flight control system featuring two parallel electromechanical actuators nominally operating in active-active mode is proposed. A ...
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
Abstract: Deep learning methods contain powerful tools for modelling nonlinear dynamic systems. However, whilst these models are useful for predicting outputs, they tend to be described by complicated ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly due to underlying medical conditions. Other factors can contribute, like ...